Skip to main content

Crockett Nigel's Form 4 filing

Bicycle Therapeutics PLC (BCYC) · filed Jul 14, 2021

Accession no.
0001209191-21-046700
Filed
Jul 14, 2021
Trade date
Jul 12-13, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions and 6 derivative transactions. Open-market sales total $2.58M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crockett NigelCIK 0001788580Officer (Chief Business Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 12, 2021Ordinary SharesMOption exerciseAcquired+4,331$11.66+$50,499.464,331Direct
Jul 12, 2021Ordinary SharesMOption exerciseAcquired+1,723$9.82+$16,919.866,054Direct
Jul 12, 2021Ordinary SharesMOption exerciseAcquired+974$15.36+$14,960.647,028Direct
Jul 12, 2021Ordinary SharesSSaleDisposed−7,028$32.03F2−$225,106.840Direct
Jul 13, 2021Ordinary SharesMOption exerciseAcquired+40,426$11.66+$471,367.1640,426Direct
Jul 13, 2021Ordinary SharesMOption exerciseAcquired+19,256$9.82+$189,093.9259,682Direct
Jul 13, 2021Ordinary SharesMOption exerciseAcquired+13,019$15.36+$199,971.8472,701Direct
Jul 13, 2021Ordinary SharesSSaleDisposed−69,580$32.41F3−$2,255,087.83,121Direct
Jul 13, 2021Ordinary SharesSSaleDisposed−3,121$33.09F4−$103,273.890Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 12, 2021Ordinary SharesMOption exerciseDisposed−4,331$0.00$0103,086Direct
Jul 12, 2021Ordinary SharesMOption exerciseDisposed−1,723$0.00$058,006Direct
Jul 12, 2021Ordinary SharesMOption exerciseDisposed−974$0.00$043,783Direct
Jul 13, 2021Ordinary SharesMOption exerciseDisposed−40,426$0.00$062,660Direct
Jul 13, 2021Ordinary SharesMOption exerciseDisposed−19,256$0.00$038,750Direct
Jul 13, 2021Ordinary SharesMOption exerciseDisposed−13,019$0.00$030,764Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.99 inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50 inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)